Growth hormone therapy in patients with Noonan syndrome.

Ann Pediatr Endocrinol Metab · 2018 · PMC6312920 · PMID 30599478

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In particular, when using the age of 11 years in male and 10 years in female as a cutoff for younger versus older age, patients who started GH therapy at a younger age showed a trend of higher gain in change to height SDS after 1 year and 2 years of treatment [ 24 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.